Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Diabetologia|September 27, 2012
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Cytokine|October 17, 2003
The JNK binding domain of islet-brain 1 inhibits IL-1 induced JNK activity and apoptosis but not the transcription of key proapoptotic or protective genes in insulin-secreting cell linesM A Nikulina, N Sandhu, Z Shamim, et al.
Diabetes|October 1, 1992
Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodiesA E Karlsen, W A Hagopian, J S Petersen, et al.
Diabetologia|July 24, 2008
Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejectionS G Rønn, A Börjesson, C Bruun, et al.
Diabetes|March 1, 1994
Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assayJ S Petersen, K R Hejnaes, A Moody, et al.
Diabetologia|April 1, 1994
A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDMC E Grubin, T Daniels, B Toivola, et al.
Diabetologia|November 19, 2002
IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysisT Sparre, U Bjerre Christensen, P Mose Larsen, et al.
The Journal of Clinical Investigation|January 1, 1993
Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes typeW A Hagopian, A E Karlsen, A Gottsäter, et al.
Diabetes|March 1, 1993
Differential expression of glutamic acid decarboxylase in rat and human isletsJ S Petersen, S Russel, M O Marshall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicityA E Karlsen, S G Rønn, K Lindberg, et al.
Pageof 7